CAS 2648009-64-5 Elebsiran - RNA / BOC Sciences

Meet our team at the 20th Annual Meeting of the Oligonucleotide Therapeutics Society in October 6-9 for expert consultation on your drug discovery projects. Shoot an email to arrange an in-person meeting.

Elebsiran

Elebsiran, an antiviral agent against hepatitis B and D virus infections, is a small interfering RNA (siRNA) therapeutic designed to target and silence specific mRNA sequences responsible for the production of pathogenic proteins. Its mechanism of action involves the degradation of targeted mRNA, thereby preventing the synthesis of proteins that contribute to disease progression.

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Catalog

BRP-02074

Synonyms

VIR-2218

CAS

2648009-64-5

Molecular Weight

487.5

Molecular Formula

C18H16F3N5O4S2

Canonical SMILES

COC(=O)C1=C2C[C@@H](CN2C(=N[C@H]1C3=C(C(=C(C=C3)F)F)F)C4=NC=CS4)NS(=O)(=O)N

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Sequence

RNA, (ugugaagcgaagugcacacuu), complex with RNA (gugugcacuucgcuucaca) (1:1)

Elebsiran - CAS 2648009-64-5

Elebsiran